First isolation of Mycobacterium kyorinense from clinical specimens in Brazil

Journal of Clinical Microbiology

Volumn 50, Issue 7, 2012, Pages 2477-2478

  Campos, Carlos Eduardo Dias ^a   De Souza Caldas, Paulo Cesar ^a   Ohnishi, Hiroaki ^b   Watanabe, Takashi ^b   Ohtsuka, Kouki ^b   Matsushima, Satsuki ^b   Ferreira, Nicole Victor ^a   Da Silva, Mariza Villas Boas ^a   Redner, Paulo ^a   De Carvalho, Luciana Distásio ^a   De Melo Medeiros, Reginalda Ferreira ^a   Abbud Filho, Jacyr Antônio ^c   Montes, Fátima Cristina Onofre Fandinho ^a   Galvão, Teca Calcagno ^a   Ramos, Jesus Pais ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c Tuberculosis Program   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; HEAT SHOCK PROTEIN 65; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN; RNA 16S; RNA POLYMERASE BETA SUBUNIT;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BRAZIL; CONTROLLED STUDY; DNA EXTRACTION; GENE SEQUENCE; GENETIC COMPATIBILITY; HSF65 GENE; HUMAN; LUNG FIBROSIS; MYCOBACTERIUM; MYCOBACTERIUM BRANDERI; MYCOBACTERIUM CELATUM; MYCOBACTERIUM KYORINENSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE; RNA GENE; RPOB GENE;

BACTERIAL PROTEINS; BRAZIL; CHAPERONIN 60; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; HUMANS; MOLECULAR SEQUENCE DATA; MYCOBACTERIUM; MYCOBACTERIUM INFECTIONS; PHYLOGENY; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 84862735447     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00023-12     Document Type: Article

References (9)

1. Butler WR, et al. 1993. Mycobacterium celatum sp. nov. Int. J. Syst. Bacteriol. 43:539-548.
2. Devulder G, Pérouse de Montclos M, Flandrois JP. 2005. A multigene approach to phylogenetic analysis using the genus Mycobacterium as a model. Int. J. Syst. Evol. Microbiol. 55:293-302.
3. Griffith DE, et al. 2007. ATS Mycobacterial Diseases Subcommittee; American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416.
4. Koukila-Kähkölä P, et al. 1995. Mycobacterium branderi sp. nov., a new potential human pathogen. Int. J. Syst. Bacteriol. 45:549-553.
5. Okazaki M, et al. 2009. Mycobacterium kyorinense sp. nov., a novel, slow-growing species, related to Mycobacterium celatum, isolated from human clinical specimens Int. J. Syst. Evol. Microbiol. 59:1336-1341.
6. Tamura K, et al. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28:2731-2739.
7. Telenti A, et al. 1993. Rapid identification of mycobacteria to the species level by polymerase chain reaction and restriction enzyme analysis. J. Clin. Microbiol. 31:175-178.
8. Vincent V, Gutierres MC. 2007. Mycobacterium: laboratory characteristics of slowly growing mycobacteria, p 573-588. In Murray PR, Baron EJ, Landry ML, Jorgensen JH, Pfaller MA (ed), Manual of clinical microbiology, 9th ed. American Society for Microbiology, Washington, DC.
9. Wada H, Yamamoto M, Okazaki M, Watanabe T, Goto H. 2009. Isolation of Mycobacterium kyorinense in a patient with respiratory failure. Ann. Intern. Med. 150:568-570.